March 4, 2020 / 12:37 PM / a month ago

BRIEF-Cytokinetics Granted European Orphan Designation For Reldesemtiv For The Treatment Of Amyotrophic Lateral Sclerosis

March 4 (Reuters) - Cytokinetics Inc:

* CYTOKINETICS GRANTED EUROPEAN ORPHAN DESIGNATION FOR RELDESEMTIV FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below